| Identification | |
| Name: | Somatostatin |
| Synonyms: | Somatostatin, cyclic;Somatostatina; |
| CAS: | 38916-34-6 |
| EINECS: | 254-186-5 |
| Molecular Formula: | C76H104N18O19S2 |
| Molecular Weight: | 1637.87816 |
| InChI: | InChI=1S/C76H104N18O19S2/c1-41(79)64(100)82-37-61(99)83-58-39-114-115-40-59(76(112)113)92-72(108)57(38-95)91-75(111)63(43(3)97)94-71(107)54(33-46-23-11-6-12-24-46)90-74(110)62(42(2)96)93-66(102)51(28-16-18-30-78)84-69(105)55(34-47-36-81-49-26-14-13-25-48(47)49)88-68(104)53(32-45-21-9-5-10-22-45)86-67(103)52(31-44-19-7-4-8-20-44)87-70(106)56(35-60(80)98)89-65(101)50(85-73(58)109)27-15-17-29-77/h4-14,19-26,36,41-43,50-59,62-63,81,95-97H,15-18,27-35,37-40,77-79H2,1-3H3,(H2,80,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.43 g/cm3 |
| Water Solubility: | H2O: 1 mg/mL |
| Solubility: | H2O: 1 mg/mL |
| Appearance: | powder |
| Specification: |
?Somatostatin (CAS NO.38916-34-6) is also named as CCRIS 3629 ; Growth hormone-release inhibiting factor: L-alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (3-14) disulfide ; Somatostatin, cyclic ; Somatostatina ; Somatostatina [INN-Spanish] ; Somatostatine ; Somatostatine [INN-French] ; Somatostatinum ; Somatostatinum [INN-Latin]?.?Somatostatin (CAS NO.38916-34-6) is?white powder. |
| Usage: | Somatostatin (CAS NO.38916-34-6) is used as growth hormone-release inhibiting factor; treatment of severe, acute hemorrhage of gastroduodenal ulcers and experimental antidiabetic. |
| Safety Data | |
 |
|
